Breaking News!

Loading...

Thursday, July 24, 2014

Miraculins Announces Publication of Peer-Reviewed Study That Demonstrates Scout DS® Is a Viable Alternative to Current Pre-Diabetes and Type 2 Diabetes Screening Methods


Study Shows Scout DS® detects abnormal glucose tolerance just as well as Fasting Plasma Glucose and HbA1c testing without blood draw or fasting

WINNIPEG, MANITOBA--(Marketwired - July 24, 2014) - Miraculins Inc. (TSX VENTURE:MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces the publication of results from the ENGINE (Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes) study, which highlights the effectiveness of the Company's Scout DS® NonInvasive Diabetes Screening Device. The study, which is available online ahead of press publication by the Journal of Clinical and Translational Endocrinology, concluded that the elimination of overnight fasting, the absence of blood, and the rapid, real-time communication of screening results are aspects of noninvasive skin fluorescence spectroscopy (Scout DS® measurement) that facilitate opportunistic screening of individuals at risk for type 2 diabetes, while delivering performance that is comparable to fasting plasma glucose and HbA1c testing for detection of abnormal glucose tolerance. The published article is entitled "Noninvasive Skin Fluorescence Spectroscopy for Detection of Abnormal Glucose Tolerance".
"While the need for effective primary screening methods for those at risk of developing type 2 diabetes is widely acknowledged, multiple obstacles limit the effectiveness of established blood-based diabetes screening methods," commented John Maynard, Vice-President Scout DS® Technology at Miraculins and a co-author of the study. "The need for a blood draw negatively impacts patient convenience and participation, while the requirement for overnight fasting by certain methods further reduces patient compliance. The need to properly handle and dispose of biohazardous waste generated by blood-based screening methods presents additional challenges in mobile screening settings such as employee wellness clinics or community health fairs."

The ENGINE trial was a prospective, multi-centre study conducted on more than 500 patients at 12 clinical sites in the United States. The purpose of the ENGINE trial was a real-world comparison of Scout DS® to fasting plasma glucose (FPG) and HbA1c (glycated hemoglobin) for type 2 diabetes screening, using a 2-hour oral glucose tolerance test (OGTT) as the reference standard. FPG and HbA1c are common laboratory-based diabetes tests. All members of the study cohort were at risk for type 2 diabetes according to the ADA (American Diabetes Association) guidelines and therefore members of the intended-use population for Scout DS®. The cohort also had a representative mixture of patient age, sex, ethnicity, and BMI (Body Mass Index).
"The publication of this additional peer-reviewed data continues to build upon the mounting evidence that Scout DS® can be an effective tool in the war on type 2 diabetes by offering a patient friendly screening method that could increase the likelihood of early stage disease detection," said Christopher J. Moreau, President and Chief Executive Officer of Miraculins.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Scout DS® is a registered trademark of Miraculins Inc. All Rights Reserved. 2014.
 

Contact Information


Miraculins Inc.
Christopher J. Moreau
President & CEO
204-477-7599
204-453-1546 (FAX)
info@miraculins.com
www.miraculins.com

Wednesday, July 23, 2014

Red Moon Potash Inc.




July 23, 2014 11:11 ET

Red Moon Potash-Drilling Update



ST. JOHN'S, NEWFOUNDLAND AND LABRADOR--(Marketwired - July 23, 2014) - Red Moon Potash Inc. ("the Company" - "Red Moon") (TSX VENTURE:RMK) announces that it has successfully completed the first of two holes at its Captain Cook salt/potash exploration program in Western Newfoundland. CC #4 was drilled to a total depth of 536 metres and encountered a gross interval of 345 metres of salt (halite) containing a potash zone of approximately 10 metres in thickness. The potash zone consists of an intercalated mixture of mudstone, salt and potash similar to the zone encountered in CC #2. The CC #4 drill results confirm the interpretation that the location is situated on a salt swell, an area of thickened salt caused by salt movement. The quality of the salt is visually similar to that observed in the CC #1 and CC #2 holes, located 1000 and 500 metres to the southwest respectively, where significant widths of high grade salt were encountered. Representative samples of the core will be assayed upon completion of the drill program. The drill rig has moved to CC #5 which is located 1000 metres east of and down dip of CC #1 and will represent the first delineation hole to step out in this direction. The purpose of the hole is to further delineate the salt deposit and to penetrate the potash at a greater depth. Drill location maps are available at the company's website www.redmoonpotash.com.

The Captain Cook salt/potash project is located in the Bay St. George Basin of Western Newfoundland near deep water ports and an airport. The Trans-Canada highway and high voltage electrical power lines cross the property. The project is delineating an evaporite package of rocks analogous to the geology containing the potash/salt mines in the Sussex basin of New Brunswick. Patrick Laracy, P. Geo, President and Corwin Northcott, P. Geo, Exploration Manager are qualified persons responsible for the contents of this news release as defined in National Instrument 43-101.
Red Moon owns a 100% working interest subject to a 3% royalty to its parent company, Vulcan Minerals Inc. (TSX VENTURE:VUL). Vulcan is providing project management services to Red Moon, capitalizing on Vulcan's drilling experience in the region.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This release may contain certain forward-looking statements. Actual events or results may differ from the Company's expectations. Certain risk factors beyond the Company's control may affect the actual results achieved. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except by law, the Company undertakes no obligation to publicly update or revise forward-looking information.
 

Contact Information


Red Moon Potash Inc.
Patrick J. Laracy LL.B, P. Geo.
President
info@redmoonpotash.com
www.redmoonpotash.com